Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/29/23
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 06/18/20
End: 02/15/22
Due: 02/15/23
Phase: N/A
Priority: Normal
Start: 04/29/22
End: 06/01/25
Due: 06/01/26
Phase: N/A
Priority: Normal
Start: 10/16/24
End: 09/30/25
Due: 09/30/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Feasibility Study for Bevonescein-Assisted Nerve Visualization in Head & Neck Surgery | NCT06227585 | Alume Biosciences, Inc. | user2@example.com | None | 2023-11-29 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |
| Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery | NCT04420689 | Alume Biosciences, Inc. | user2@example.com | None | 2020-06-18 | 2022-02-15 | 2023-02-15 | - | - | 2025-07-14 |
| Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery | NCT05377554 | Alume Biosciences, Inc. | user2@example.com | None | 2022-04-29 | 2025-06-01 | 2026-06-01 | - | - | 2025-07-14 |
| A Study of Bevonescein in Patients Undergoing Abdominopelvic Surgery | NCT06662097 | Alume Biosciences, Inc. | user2@example.com | None | 2024-10-16 | 2025-09-30 | 2026-09-30 | - | - | 2025-07-14 |